Casandra
Casandra Test Code QD18100Version 1 (DRAFT)
Performing Lab
QHerit™ 421 Diseases, Female
Clinical Use
Order TestUse
QHerit™ 421 Diseases, Female is a carrier‑screening test designed to assess genetic variations across 421 genes associated with disorders that may be inherited by offspring. It is intended for use in adult female patients who may be carriers, to inform reproductive planning and assess risk of passing variants to children.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
Targeted next‑generation sequencing assessing variants across 421 genes associated with heritable disorders in females.
NGS sequencing • Targeted
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
10 mL
Minimum Volume
2 mL
Container
EDTA (lavender‑top) tube
Collection Instructions
Collect 10 mL whole blood in EDTA (lavender‑top) tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | Unacceptable |
Related Tests
Other tests from different labs that may be relevant
GeneAware™ Expanded Panel (Female)
Baylor Genetics
Inheritest® 14‑gene Panel
Labcorp
GeneAware™ Expanded Panel (Male)
Baylor Genetics
Inheritest® 100 PLUS Panel
Labcorp
Horizon™ – Advanced Carrier Screening
Natera
Expanded Carrier Screen by Next Generation Sequencing with Fragile X
ARUP Laboratories
Expanded Carrier Screen by Next Generation Sequencing
ARUP Laboratories
Carrier Screen, Focused Panel
Mayo Clinic Lab
Common Hereditary Cancer Screening Panel
Prevention Genetics
Comprehensive Hereditary Cancer Panel
Prevention Genetics